Insider · CIK 0001294192

Horn Margaret A

Reports to the SEC for 4 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001294192

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−76 sh	$195.01	−$14.8K	154,571
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,891 sh	$199.30	−$975K	149,680
2026-06-17	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+573 sh	$40.74	+$23.3K	155,220
2026-06-17	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,302 sh	$29.80	+$98.4K	158,522
2026-06-17	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25.7K sh	$26.50	+$682K	184,247
2026-06-17	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−29.6K sh	$160.12	−$4.74M	154,647
2026-06-17	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−573 sh	—	—	75,075
2026-06-17	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,302 sh	—	—	71,750
2026-06-17	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25.7K sh	—	—	114,275
2026-06-15	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+15.5K sh	$40.74	+$633K	173,768
2026-06-15	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+44.9K sh	$29.80	+$1.34M	218,622
2026-06-15	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−60.4K sh	$160.17	−$9.67M	158,222
2026-06-15	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15.5K sh	—	—	75,648
2026-06-15	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−44.9K sh	—	—	75,052
2026-06-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,094 sh	$42.45	+$46.4K	159,316
2026-06-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,906 sh	$40.74	+$363K	168,222
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−1,315 sh	$144.28	−$190K	166,907
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−885 sh	$145.15	−$128K	166,022
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−700 sh	$146.04	−$102K	165,322
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−500 sh	$147.27	−$73.6K	164,822
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−1,800 sh	$148.72	−$268K	163,022
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,600 sh	$149.64	−$688K	158,422
2026-06-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−200 sh	$150.17	−$30K	158,222
2026-06-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,094 sh	—	—	0
2026-06-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,906 sh	—	—	91,194
2026-03-17	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,583 sh	$99.48	−$456K	157,570
2026-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Operating Officer	AAward	+21.1K sh	—	—	162,153
2026-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+47.6K sh	—	—	47,600
2026-01-07	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+51.4K sh	$42.45	+$2.18M	192,459
2026-01-07	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+23.6K sh	$29.80	+$703K	216,053
2026-01-07	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−53.1K sh	$100.02	−$5.31M	162,957
2026-01-07	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−20.2K sh	$101.79	−$2.06M	142,753
2026-01-07	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−1,700 sh	$102.90	−$175K	141,053
2026-01-07	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−51.4K sh	—	—	1,094
2026-01-07	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−23.6K sh	—	—	119,906
2025-12-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,847 sh	$76.82	−$372K	141,053
2025-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,775 sh	$45.82	−$219K	145,900
2025-06-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−3,510 sh	$39.83	−$140K	150,675
2025-06-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−3,575 sh	$156.12	−$558K	154,647
2025-06-12	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+25K sh	—	—	82,650
2025-06-12	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-03-17	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−3,058 sh	$39.04	−$119K	153,533
2025-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Operating Officer	AAward	+28.6K sh	—	—	156,591
2025-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,100
2024-12-16	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−4,329 sh	$45.40	−$197K	127,991
2024-10-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+44.6K sh	$4.09	+$183K	176,951
2024-10-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,369 sh	$4.09	+$22K	182,320
2024-10-11	RVMDRevolution Medicines, Inc.S Sale	Chief Operating Officer	SSale	−50K sh	$50.34	−$2.52M	132,320
2024-10-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−44.6K sh	—	—	0
2024-10-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,369 sh	—	—	97,382

Recent filings

Accepted (ET)
Sep 184
Horn Margaret A0001294192-26-000007
SEC(opens sec.gov)
Jun 174
Horn Margaret A0001610717-26-000230
SEC(opens sec.gov)
Jun 154
Horn Margaret A0001610717-26-000216
SEC(opens sec.gov)

Companies

Address

REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063